Comparative Effects Of Trichloroacetic Chemical Peel And Fractional Laser
Launched by JOSE ROBERTO CORTELLI · Jun 23, 2025
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
More than aesthetics, the search for orofacial harmonization treatments has increased when the negative emotional impact of some facial conditions such as melasma and acne scars is recognized. This randomized clinical trial will evaluate the effects of chemical peel with 35% TCA (trichloroacetic acid)associated with croton oil. And to compare the results with its isolated formulation containing only 35% TCA and with two types of fractional laser (2940nm Er-YAG and 1640nm Nd-YAG) in orofacial harmonization procedures. This study will be based on a sample of 100-120 participants at least 18 y...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Men or women
- • aged 18 or over
- • acne scars, melasma or clear signs of photoaging and evident wrinkles
- • participants with acne scars or melasma will be included if they have never undergone treatment or if previous treatment has been ineffective.
- Exclusion Criteria:
- • phototype VI
- • autoimmune and dermatological diseases
- • known allergies to the components of the formulations
- • patients who prefer other treatment options
- • history of keloids
- • pregnant women
- • breastfeeding women
- • women of childbearing age who do not adopt a valid method of contraception
About Jose Roberto Cortelli
Jose Roberto Cortelli is a clinical trial sponsor specializing in advancing medical research through the design and oversight of clinical studies. With a focus on generating high-quality, evidence-based data, Cortelli contributes to the development of innovative therapeutic interventions aimed at improving patient outcomes. His involvement ensures rigorous adherence to regulatory standards and ethical guidelines throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taubaté, , Brazil
Taubaté, , Brazil
Patients applied
Trial Officials
Sheila C Cortelli, Doctorate
Principal Investigator
University of Taubate
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported